Early-feasibility Study to Evaluate Usability and Safety of the Watch-Transcutaneous Electrical Acustimulation (TEA) Device

Launched by UNIVERSITY OF MICHIGAN · Apr 9, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new device called the Watch-Transcutaneous Electrical Acustimulation (TEA) Device. The main goal is to see how safe and easy it is to use this device. Although the study is currently designed for healthy participants, it is a first step towards helping cancer patients who may experience symptoms from chemotherapy in the future.

To participate, you need to be between the ages of 65 and 74 and be willing to come to the clinic for two scheduled visits. You should also be able to understand the study procedures and agree to fill out some questionnaires. However, if you have certain implanted medical devices, are part of another clinical study, or have health issues that might make participation difficult, you won't be eligible. If you decide to take part, you'll help researchers gather important information that could lead to new ways to support cancer patients in managing their symptoms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants that are willing and able to come to the clinic for two scheduled visits
• • Participants are capable of understanding clinical study procedures
• • Participants agree to complete the questionnaires
• Exclusion Criteria:
• • Participants with implanted medical devices for electrical stimulation (e.g. cardiac pacemaker)
• • Those enrolled in a concurrent clinical study
• • Those unable to comply with the study protocol due to a disease, psychiatric illness, alcoholism, substance abuse, geographic distance, or other factors that would place the study participant at increased risk or preclude the study participant's full compliance with or completion of the study